Azienda Socio Sanitaria Locale N. 8 Di Cagliari — Clinical Trial Site

15 Registered trials

7 Currently recruiting

Organisation

Azienda Socio Sanitaria Locale N. 8 Di Cagliari

Location

Cagliari, Italy

Identifier

ORG-100048482

Address

Via Is Mirrionis 92, 09121, Italy

Departments

7409: Centro Sclerosi Multipla
Cardiology and intensive coronary care unit
Centro Sclerosi Multipla
Neurologia
Neurologist
Oncoematologia Pediatrica e Patologia della Coagulazione
Ospedale “R. Binaghi" - Centro Sclerosi Multipla
Pediatric Clinic and Rare Disease - Microcitemico Hospital, "A. Cao"
Presidio Ospedaliero Businco
SC Microcitemie e Anemie Rare
U.O. di Neurologia e Unità di Neuroriabilitazione
UO centro Sclerosi Multipla

Clinical trials at this site (15)

Search interface

A clinical trial to find out how well LOU064 (remibrutinib) works and how safe it is for people with secondary progressive multiple sclerosi… Recruiting

2025-521546-23-00 Secondary progressive multiple sclerosis 5 2026-04-21
Non-inferiority study of frexalimab subcutaneous administration compared to intravenous administration in adult participants with multiple s… Recruiting

2024-519304-28-00 Multiple Sclerosis 5 2026-04-20
A study to investigate long-term safety and tolerability of tolebrutinib in participants with multiple sclerosis Recruiting

2023-503631-18-01 Nervous system diseases 5 2024-05-20
A Phase 3, multicenter, randomized, double-blind, placebo-controlled, parallel-group study to evaLuate the effIcacy and safety of abeLacimab… Recruiting

2023-503224-66-00 Atrial Fibrillation 5 2023-10-31
A study with eptinezumab in children and adolescents (6 to 17 years) with chronic or episodic migraine (REJOIN) Recruiting

2022-502917-27-00 Migraine 5 2023-03-07
A Study With Eptinezumab in Adolescents (12-17 Years) With Chronic Migraine (PROSPECT-2) Recruiting

2024-510656-13-00 Migraine 5 2022-11-08
Bacille Calmette-Guérin (BCG) vaccine in Radiologically Isolated Syndrome (RIS) Recruiting

2024-518901-16-00 RIS (Radiologically Isolated Syndrome) 4 2019-07-29
LCH-IV International Collaborative Treatment Protocol for Children and Adolescents with Langerhans Cell Histiocytosis Ended

2024-512676-36-00 Langerhans Cell Histiocytosis 10 2024-10-09
A study to Evaluate the Efficacy and Safety of Mitapivat in Subjects With Transfusion-Dependent Alpha- or Beta-Thalassemia (ENERGIZE-T) Ended

2024-512747-23-00 Transfusion-Dependent Alpha- or Beta-Thalassemia 5 2024-07-30
A study to Evaluate the Efficacy and Safety of Mitapivat in Subjects With Non Transfusion-Dependent Alpha- or Beta-Thalassemia (ENERGIZE) Ended

2024-512745-16-00 Non–Transfusion-Dependent Alpha- or Beta-Thalassemia 5 2022-04-13
A Study to Evaluate the Efficacy and Safety of Fenebrutinib Compared with Teriflunomide in Adult Patients with Relapsing Multiple Sclerosis Ended

2022-502618-95-00 Relapsing multiple sclerosis (RMS) 5 2020-11-24
A superiority study to compare the effect of Panzyga versus placebo in patients with pediatric acute-onset neuropsychiatric syndrome Ended

2024-511673-30-00 Pediatric acute-onset neuropsychiatric syndrome (PANS) 5 2023-03-20
A Phase 2 double-blind, randomized, placebo-controlled study evaluating the effect of SAR443820 on serum neurofilament levels in participant… Ended

2023-509078-45-00 Multiple sclerosis 4 2022-12-19
Primary Progressive Multiple Sclerosis (PPMS) Study of Bruton's Tyrosine Kinase (BTK) Inhibitor tolebrutinib (SAR442168) (PERSEUS) Ended

2024-514495-41-00 Primary Progressive Multiple Sclerosis 5 2020-11-04
Multicenter trial with carfilzomib combined with lenalidomide or cyclophopshamide with or without autologous transplant in newly diagnosed m… Ended

2024-516630-35-01 NEWLY DIAGNOSED MULTIPLE MYELOMA (MM) PATIENTS ELEGIBLE 4 2015-01-12